Federated Hermes, Inc. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-09 2:38 pm Purchase | 2021-06-30 | 13G | Astria Therapeutics, Inc. ATXS | FEDERATED HERMES INC. FHI | 260,456 1.990% | 39 (+0.01%) | Filing |
| 2021-04-09 2:17 pm Purchase | 2021-03-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FEDERATED HERMES INC. FHI | 1,950,000 10.160% | 714,967 (+57.89%) | Filing |
| 2021-02-12 3:06 pm Purchase | 2020-12-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FEDERATED HERMES INC. FHI | 1,235,033 6.340% | 1,235,033 (New Position) | Filing |
| 2021-02-12 1:14 pm Unchanged | 2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS | FEDERATED HERMES INC. FHI | 260,417 7.570% | 0 (Unchanged) | Filing |
| 2020-11-10 1:53 pm Sale | 2020-10-31 | 13G | Astria Therapeutics, Inc. ATXS | FEDERATED HERMES INC. FHI | 260,417 7.570% | -93,383 (-26.39%) | Filing |